Predominance of the Metastatic Phenotype in Somatic Cell Hybrids of the K-1735 Murine Melanoma

Cancer Research

Volumn 51, Issue , 1991, Pages 6292-6298

  Fidler, Isaiah J ^a,a   Pathak, Sen ^a   Chernajovsky, Yuti ^a   Tucker, Susan L ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; CELL FUSION; CONTROLLED STUDY; GENETIC TRANSFECTION; MELANOMA CELL; METASTASIS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; TUMOR CELL LINE;

ANIMAL; DRUG RESISTANCE; FEMALE; HYBRID CELLS; HYGROMYCIN B; KARYOTYPING; LUNG NEOPLASMS; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C3H; MICE, NUDE; NEOMYCIN; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; PHENOTYPE; SPECIFIC PATHOGEN-FREE ORGANISMS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0026317633     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (74)

1. Fidler, L.J. Critical factors in the biology of human cancer metastasis. Cancer Res., 50:6130-6138, 1990.
2. Nicolson. G. L. Tumor cell instability, diversification, and progression to the metastatic phenotype: from oncogene to oncofetal expression. Cancer Res., 47: 1473-1487, 1987.
3. Bishop, J. M. The molecular genetics of cancer. Science (Washington DC), 235:305-311, 1987.
4. Fidler, I. J., and Balch. C. M. The biology of cancer metastasis and implica tions for therapy. Curr. Probi. Surg., 24: 137-209. 1987.
5. Poste, G., and Fidler, I. J. The pathogenesis of cancer metastasis. Nature (Lond.). 283: 139-146, 1980.
6. Liotta, L. A. Gene products which play a role in cancer invasion and metastasis. Breast Cancer Res. Treat., II: II3-124, 1988.
7. Fidler, I. J., and Radinsky, R. Genetic control of cancer metastasis (Editorial). J. Nail. Cancer Inst., 82:166-168, 1990.
8. Fidler. L. J., Gruys, E., Cifone, M. A., Barnes. Z., and Bucana. C. Demon stration of multiple phenotypic diversity in a murine melanoma of recent origin. J. Nati. Cancer Inst., 67: 947-956, 1981.
9. Aukerman, S. L., Price, J. E., and Fidler, I. J. Different deficiencies in the prevention of tumorigenic-low-metastatic murine K-1735 melanoma cells from producing metastases. J. Nail. Cancer Inst., 77:915-924, 1986.
10. Fidler. I. J., and Poste, G. The cellular heterogeneity of malignant neoplasms: implications for adjuvant chemotherapy. Semin. Oncol., 12: 207-221. 1985.
11. Hart. I. R., Goode, N. T., and Wilson, R. E. Molecular aspects of the metastatic cascade. Biochim. Biophys. Acta. 989: 65-84. 1989.
12. Sobel, M. E. Metastasis suppressor genes. J. Nati. Cancer Inst., 82: 267-276, 1990.
13. Shih, C., and Weinberg, R. A. Isolation of a transforming sequence from a human bladder cancer. Cell, 29: 161-169. 1982.
14. Harris, H., Miller, O. J., Klein, G., Worst. P.,and Tachibana,T. Suppression of malignancy by cell fusion. Nature (Lond.), 223: 363-368. 1969.
15. Harris. H. Suppression of malignancy in hybrid cells: the mechanism. J. Cell Sci., 79:83-94. 1985.
16. Stanbridgc, E. G., Flandermeyer, R. R., Daniels, D. W., and Nelson-Rees, W. A. Specific chromosome loss associated with the expression of tumorigenicity in human cell hybrids. Somatic Cell Genet., 7: 699-712. 1981.
17. Stanbridge, E. J., Der, C. J., Doersen, C. J., Nishimi, R. Y., Peehl. D. M., Weissman, B. E., and Wilkinson, J. E. Human cell hybrids: analysis of transformation and tumorigenicity. Science (Washington DC). 215: 252-259, 1982.
18. Yunis. J. J., and Ramsay. N. Retinoblastoma and subband deletion of chromosome 13. Am. J. Dis. Child., 432:161-163, 1979.
19. Cavenee. W. K., Dryja. T. P., Phillips. R. A., Benedici, W. F., Godbout. R., Gallic. B. L., Murphree, A. L., Strong, L. C., and White. R. L. Expression of recessive alaelesby chromosomal mechanisms in retinoblastoma. Nature (Lond.), 305: 779-784. 1983.
20. Sager. R. Tumor suppressor genes: the puzzle and the promise. Science (Washington DC). 276: 1406-1412. 1989.
21. Friend, S. H., Bernards, R., Rogelj, S., Weinberg, R. A., Rappaport, J. M., Albert, D. M., and Dryja, T. P. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature (Lond.), 323: 643-646, 1986.
22. Lee, W. H., Bookstein, R., Hong, F., Young, L. H., Shew, J. Y., and Lee, E. Y-H. P. Human retinoblastoma susceptibility gene: cloning, identification, and sequence. Science (Washington DC), 235: 1394-1399, 1987.
23. Benedict, W. F., Murphree, A. L., Benerjee, A., Spina, C. A., Sparkes, M. C., and Sparkes, R. C. Patient with 13 chromosome deletion: evidence that the relinoblastoma gene is a recessive cancer gene. Science (Washington DC), 219: 973-975. 1983.
24. Ramshaw, I. A., Carlsen, S., Wang. H. C., and Badenoch-Jones, P. The use of cell fusion to analyze factors involved in tumor cell metastasis. Int. J. Cancer, 32:471-478, 1983.
25. Sidebottom, E., and Clark, S. R. Cell fusion segregates progressive growth from metastasis. Br. J. Cancer, 47: 399-406, 1983.
26. Layton, M. G., and Franks, L. M. Selective suppression of metastasis but not tumorigenicity of a mouse. Int. J. Cancer, 37: 723-730, 1986.
27. Hart, I. R. Tumor cell hybridization and neoplastic progression. In Nicolson, G. L., and Milas, L. (eds.), Cancer Invasion and Metastasis: Biological and Therapeutic Aspects, pp. 133-143. New York: Raven Press, 1984.
28. Larizza, L., Schirrmacher, V., and Pfluger, E. Acquisition of high metastatic capacity after in vitro fusion of a nonmetastatic tumor line with a bone marrow-derived macrophage. J. Exp. Med., 460:1579-1584, 1984.
29. Lagarde, A. E. Sporadic somatic fusion between MDAY-D2 murine tumor cells and DBA/2 host cells: role in metastasis. Int. J. Cancer, 37: 905-910, 1986.
30. Lagarde, A. E., and Kerbel, R. S. Somatic cell hybridization in vivo and in vitro in relation to the metastatic phenotype. Biochim. Biophys. Acta, 823: 81-110, 1985.
31. Larizza, L., and Schirrmacher, V. Somatic cell fusion as a source of genetic rearrangement leading to metastatic variants. Cancer Metastasis Rev., 3: 192-222, 1984.
32. Larizza. L., Schirrmacher, V., Graf, L., Pfluger, E., Perez-Martinez, M., and Siciln. F. Suggestive evidence that a highly metastatic variant ESG of the I cell lymphoma EG is derived from spontaneous fusion with a host macro phage. Int. J. Cancer, 34:699-701, 1984.
33. Kerbel, R. S., Lagarde, A. E., Dennis, J., and Danaghue, T. P. Spontaneous fusion in vivo between normal host and tumor cells: possible contribution to tumor progression and metastasis studied with a lectin-resistant tumor. Mol. Cell Biol., 3: 523-538, 1983.
34. Roos, E., La Riviere, G., Collard, J. G., Stukart, M. J., and DeBaetselier, P. Invasiveness of T-cell hybridomas in vitro and their metastatic potential in vivo. Cancer Res., 45: 6238-6243, 1985.
35. DeBaetselier, P., Gorelic, E., Eshar, Z., Ron, Y., Katzav, S., Feldman, M., and Segal, S. Metastatic properties conferred on nonmetastatic tumors by hybridization of spleen B-lymphocytes with plasmocytoma cells. J. Nati. Cancer Inst., 67: 1079-1087, 1981.
36. DeBatselier, P., Roos, E., Brys, L., and Feldman, M. Generation of invasive and metastatic variants of a nonmetastatic T-cell lymphoma by in vivo fusion with normal host cells. Int. J. Cancer, 34: 731-738, 1984.
37. Collard, J. G., Van de Poll, M., Scheffer, A., Roos, E., Hopman, A. H. M., Geurts van Kessel, A. H. M., and Van Dongen, J. J. M. Location of genes involved in invasion and metastasis of human chromosomes 7. Cancer Res., 47: 6666-6670, 1987.
38. Kripke, M. L. Demonstration of multiple phenotypic diversity in a murine melanoma of recent origin. J. Nati. Cancer Inst., 67: 947-956, 1981.
39. Talmadge, J. E., and Fidler, I. J. Enhanced metastatic potential of tumor cells harvested from spontaneous metastasesof heterogeneous murine tu mors. J. Nail. Cancer Inst., 69: 975-980. 1982.
40. Schackert, G., and Fidler, L. J. Development of in vivo models for studies of brain metastasis. Int. J. Cancer, 41: 589-594, 1988.
41. Talmadge, J. E., Wolman. S. R., and Fidler, I. J. Evidence for the clonal origin of spontaneous metastases. Science (Washington DC), 217: 361-363, 1982.
42. Fidler, I. J., and Talmadge, J. E. Evidence that intravenously derived murine pulmonary melanoma metastasescan originate from the expansion of a single tumor cell. Cancer Res., 46: 5167-5171, 1986.
43. Graham, F. L., and Van der Eb, A. J. A new technique for the assay of infectivity of human adenovirus 5DNA. Virology, 52: 456-467, 1973.
44. Southern, P. J., and Berg, P. Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promotor. J. Mol. Appi. Genet.,/: 327-341, 1982.
45. Blochlinger, K., and Diggelmann, H. Hygromycin B phosphotransferase as a selectable marker for DNA transfer experiments with higher eucaryotic cells. Mol. Cell. Biol., 4: 2929-2931, 1984.
46. Davidson, R. L., and Gerald, P. S. Improved techniques for induction of mammalian cell hybridization by polyethylene glycol. Somatic Cell Genet., 2: 165-176, 1976.
47. Pathak. S. Chromosome banding techniques. J. Reprod. Med., 17: 25-28, 1976.
48. Sugimoto, Y., Oh-hara, T., Watanabe, M., Saito, H., Yamori, T., and Tsuruo, T. Acquisition of metastatic ability in hybridomas between two low melastatic clones of murine colon carcinoma 26 defective in either platelet-aggregating activity or in vivo growth potential. Cancer Res., 47:4396-4401, 1987.
49. Poste, G. Pathogenesis of metastatic disease: implications for current therapy and for the development of new therapeutic strategies. Cancer Treat. Rep., 70: 183-199. 1986.
50. Goldenberg, D. M., Pavia, R. A., and Tsao, M. C. In vivo hybridization of human tumor and normal hamster cells. Nature (Lond.), 250: 649-651, 1974.
51. Kim, B. S., Liang. W., and Cohen, E. P. Tumor-specific immunity induced by somatic hybrids. 1. Lack of relationship between immunogenicity and tumorigenicity of selected hybrids. J. Immunol., 123: 733-738, 1979.
52. LeGrue, S. J., Ananthaswamy. H. N., and Simcik, W. J. Afferent and efferent specificity in the induction and elicitation of parental cross-protective im munity by an immunogenic murine tumor variant: associative recognition of a unique tumor-specific antigen on somatic cell hybrids. Cancer Res., 49: 4747-4751, 1989.
53. Fidler, I. J. Rationale and methods for the use of nude mice to study the biology and therapy of human cancer metastasis. Cancer Metastasis Rev., 5: 29-49, 1986.
54. Price, J. E., Aukerman. S. L., Ananthaswamy, H. N., McLntyre, B. W., Schackert, G., Schackert, H. K., and Fidler. I. J. Metastatic potential of cloned murine melanoma cells transfected with activated c-Ha-ras. Cancer Res., 49:4274-4281, 1989.
55. Pathak, S., Staroselsky, A. N., and Fidler, I. J. Specific chromosomal defects associated with metastatic potential in K-1735 melanoma clones: involve ment of chromosomes 4 and 14. Cancer Genet. Cytogenet., in press, 1991.
56. Ichikawa. T., and Isaacs, J. T. Genetic factors and suppression of metastatic ability of prostatic cancer. J. Urol. (Suppl.). 143: 227A. 1990.
57. Pereira-Smith. O. M., and Smith. J. R. Evidence for the recessive nature of cellular immortality. Science (Washington DC), 221: 964-996, 1983.
58. Weissman, B. E., and Stanbridge, E. J. Complementation of the tumorigenic phenotype in human cell hybrids. J. Nati. Cancer Inst., 70: 667-672, 1983.
59. Geiser, A. G., Anderson, M. J., and Stanbridge. E. J. Suppression of tumor igenicity in human hybrids derived from cell lines expressed different acti vated ras oncogenes. Cancer Res., 49: 1572-1577, 1989.
60. Bradley. M. O., Kraynak, A. R., Storer, R. D., and Gibbs. J. B. Experimental metastasis in nude mice of NIH 3T3 cells containing various raj genes. Proc. Nati. Acad. Sci. USA. 83: 5277-5281, 1986.
61. Muschel, R. J., Williams, J. E., Lowy, D. R., and Liotta, L. A. Harvey ras induction of metastatic potential depends upon oncogene activation and the type of recipient cell. Am. J. Pathol., 121: 1-8. 1985.
62. Chambers, A. F., and Ling, V. Selection for experimental metastatic ability of heterologous tumor cells in the chick embryo after DN A-mediated transfer. Cancer Res., 44: 3970-3975, 1984.
63. Radler-Pohl, A., Pohl, J., and Schirrmacher, V. Selective enhancement of metastatic capacity in mouse bladder carcinoma cells after transfection with DNA from liver metastasesof human colon carcinoma. Int. J. Cancer, 41: 840-846, 1988.
64. Schalken, J. A., Ebeling, S. B., Isaacs, J. T., Treiger, B., Bussemakers, M. J. G., de Jong, M. E. M., and Van de Ven, W. J. M. Down modulation of fibronectin messenger RNA in metastasizing rat prostatic cancer cells re vealed by differential hybridization analysis. Cancer Res., 48: 2042-2046, 1988.
65. Matrisian, L. M., Bowden, G. T., Kriegg, P., Furstenberger, G., Briand, J.P., Leroy, P., and Breathnach, R. The RNA coding the secreted protease transin is expressed more abundantly in malignant than in benign tumors. Proc. Nati. Acad. Sci. USA, 83: 9413-9417, 1986.
66. Ebralidze, A., Tulchinsky, E., and Grigorian, M. Isolation and characterisa tion of a gene specifically expressed in different metastatic cells and whose deducted gene product has a high degree of homology to a Ca bind protein family. Genes Dev., 3: 1086-1093, 1989.
67. LaBishe, R. A., Yoshida, M., Gallick, G. E., Irimura, T., Robberson, D. L., Klostergaard, J., and Nicolson, G. L. Gene expression and tumor cell escape from host effector mechanisms in murine large cell lymphoma. J. Cell. Biochem., 36: 393-403, 1988.
68. Elvin, P., Kerr, I. B., McArdle, C. S., and Birnie, G. D. Isolation and preliminary characterisation of cDNA clones representing mRNAs associated with tumor progression and metastasis in colorectal cancer. Br. J. Cancer, 57:36-42, 1988.
69. Phillips, S. M., Bendali, A. J., and Ramshaw, I. A. Isolation of gene associated with high metastatic potential in rat mammary adenocarcinoma. J. Nati. Cancer Inst., 82: 199-203. 1990.
70. Steeg, P. S., Bevilacqua, G. B., Kopper. L., Thorgeirsson, U. P., Talmadge, J. E., Liotta, L. A., and Sobel, M. E. Evidence for novel gene associated with low tumor metastatic potential. J. Nati. Cancer Inst., 80: 200-204, 1988.
71. Rosengard, A. M., Krutzsch, H. C., Shearn, A., Liotta, L. A., and Steeg, P. S. Reduced NM23/awd protein in tumor metastasis and aberrant Drosophila development. Nature (Lond.), 342: 177-180, 1989.
72. Dear, T. N., Ramshaw, I. A., and Kefford. R. F. Differential expression of a novel gene, WDNM1, in nonmetastatic rat mammary adenocarcinoma cells. Cancer Res., 48: 5203-5209, 1988.
73. Dear, T. N., McDonald, D. A., and Kefford, R. F. Transcriptional downregulation of a rat gene, WDNM2, in metastatic DMBA-8 cells. Cancer Res., 48: 5323-5328, 1989.
74. Kerbel, R. S. Towards an understanding of the molecular basis of the metastatic phenotype. J. Nati. Cancer Inst., 9: 329-337, 1989.